84 related articles for article (PubMed ID: 16343875)
21. Design and evaluation of microporous membrane coated matrix tablets for a highly water soluble drug.
Mishra M; Mishra B
Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):995-1000. PubMed ID: 20606356
[TBL] [Abstract][Full Text] [Related]
22. Dissolution rate enhancement of parabens in PEG solid dispersions and its influence on the release from hydrophilic matrix tablets.
Tajarobi F; Abrahmsén-Alami S; Larsson A
J Pharm Sci; 2011 Jan; 100(1):275-83. PubMed ID: 20572053
[TBL] [Abstract][Full Text] [Related]
23. Naproxen release from sustained release matrix system and effect of cellulose derivatives.
Sarfraz MK; Rehman NU; Mohsin S
Pak J Pharm Sci; 2006 Jul; 19(3):251-5. PubMed ID: 16935834
[TBL] [Abstract][Full Text] [Related]
24. The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.
Shokri J; H Zarrintan M; Ghanbarzadeh S; Arash Z; Farahani A; Adibkia K
Drug Res (Stuttg); 2013 Aug; 63(8):414-9. PubMed ID: 23599037
[TBL] [Abstract][Full Text] [Related]
25. Drug release phenomena within a hydrophobic starch acetate matrix: FTIR mapping of tablets after in vitro dissolution testing.
Pajander J; Soikkeli AM; Korhonen O; Forbes RT; Ketolainen J
J Pharm Sci; 2008 Aug; 97(8):3367-78. PubMed ID: 18085712
[TBL] [Abstract][Full Text] [Related]
26. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Emara LH; Taha NF; Badr RM; Mursi NM
Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
[TBL] [Abstract][Full Text] [Related]
27. Graft copolymers of ethyl methacrylate on waxy maize starch derivatives as novel excipients for matrix tablets: drug release and fronts movement kinetics.
Marinich JA; Ferrero C; Jiménez-Castellanos MR
Eur J Pharm Biopharm; 2012 Apr; 80(3):674-81. PubMed ID: 22210473
[TBL] [Abstract][Full Text] [Related]
28. Matrix type controlled release systems: I. Effect of percolation on drug dissolution kinetics.
Bonny JD; Leuenberger H
Pharm Acta Helv; 1991; 66(5-6):160-4. PubMed ID: 1784581
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of hydrophilic matrix tablets based on Carbopol(®) 971P and low-viscosity sodium alginate for pH-independent controlled drug release.
Al-Zoubi NM; AlKhatib HS; Obeidat WM
Drug Dev Ind Pharm; 2011 Jul; 37(7):798-808. PubMed ID: 21247372
[TBL] [Abstract][Full Text] [Related]
30. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
[TBL] [Abstract][Full Text] [Related]
31. Study of the critical points of HPMC hydrophilic matrices for controlled drug delivery.
Miranda A; Millán M; Caraballo I
Int J Pharm; 2006 Mar; 311(1-2):75-81. PubMed ID: 16446063
[TBL] [Abstract][Full Text] [Related]
32. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
Franek F; Holm P; Larsen F; Steffansen B
Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
[TBL] [Abstract][Full Text] [Related]
33. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
Uhumwangho MU; Okor RS
Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
Uhumwangho MU; Okor RS
Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
[TBL] [Abstract][Full Text] [Related]
35. Micro-porous surfaces in controlled drug delivery systems: design and evaluation of diltiazem hydrochloride controlled porosity osmotic pump using non-ionic surfactants as pore-former.
Adibkia K; Ghanbarzadeh S; Shokri MH; Arami Z; Arash Z; Shokri J
Pharm Dev Technol; 2014 Jun; 19(4):507-12. PubMed ID: 23763379
[TBL] [Abstract][Full Text] [Related]
36. Sustained release matrix tablets prepared from cospray dried mixtures with starch hydrophobic esters.
Sakhnini N; Al-Zoubi N; Al-Obaidi GH; Ardakani A
Pharmazie; 2015 Mar; 70(3):177-82. PubMed ID: 25980178
[TBL] [Abstract][Full Text] [Related]
37. Experiment on formulation and drug release behavior of porosity asymmetric membrane capsules in vitro.
Fu HX; Li H; Zhang FZ; Zhao YZ; Wan CW; Chen MT; Jia XC; Yan L; Sun CC; Xu YY
Drug Dev Ind Pharm; 2012 Jun; 38(6):670-8. PubMed ID: 22469006
[TBL] [Abstract][Full Text] [Related]
38. Assessment of xanthan gum based sustained release matrix tablets containing highly water-soluble propranolol HCl.
Ali A; Iqbal M; Akhtar N; Khan HM; Ullah A; Uddin M; Khan MT
Acta Pol Pharm; 2013; 70(2):283-9. PubMed ID: 23614284
[TBL] [Abstract][Full Text] [Related]
39. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
Dave VS; Fahmy RM; Bensley D; Hoag SW
Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
[TBL] [Abstract][Full Text] [Related]
40. Testing lyoequivalency for three commercially sustained-release tablets containing diltiazem hydrochloride.
Maswadeh HA; Al-Hanbali OA; Kanaan RA; Shakya AK; Maraqa A
Acta Pol Pharm; 2010; 67(1):93-7. PubMed ID: 20210085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
